Central Screening enhances trial enrollment by integrating technology and expert oversight, streamlining the process for community oncology practices. The system utilizes Genospace to match patient ...

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

Subcutaneous daratumumab with lenalidomide significantly increased MRD-negative conversion rates compared to lenalidomide ...

Trastuzumab deruxtecan (T-DXd) significantly improves IDFS over trastuzumab emtansine (T-DM1) in high-risk HER2-positive early breast cancer post-neoadjuvant therapy. The DESTINY-Breast05 trial ...

Early-stage squamous cell carcinoma of the esophagus is primarily treated with endoscopic resection, while esophagectomy or chemoradiotherapy may be considered for select patients based on staging and ...

David Chism, MD: For pairing it with the immunotherapy, I would prefer just 1 chemotherapy rather than ...

Cancer care for younger adults emphasizes emotional well-being and multidisciplinary support, transforming treatment ...

Shane Dormady, MD, discusses the unique emotional care needs of young adults with cancer, emphasizing hope and holistic support for better outcomes. Cancer care for younger adults emphasizes emotional ...

The FDA approved Guardant 360 CDx for identifying ESR1 mutations in advanced breast cancer patients eligible for imlunestrant treatment. Imlunestrant showed a 38% reduction in disease progression risk ...

In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...

Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...

The challenge of managing relapsed or refractory B-cell malignancies continues to thwart the efforts of oncologists and ...